MASSELLI, MARIKA
MASSELLI, MARIKA
Chimica 'Ugo Schiff' - DICUS
A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies.
2012 N. Shimasaki; H. Fujisaki; D. Cho; M. Masselli; T. Lockey ; P. Eldridge; W. Leung; D. Campana
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.
2011 S.Pillozzi; M.Masselli; E.De Lorenzo; B.Accordi; E.Cilia; O.Crociani; A.Amedei; M.Veltroni; M.D’Amico; G.Basso; A.Becchetti; D.Campana; A.Arcangeli
Deregulation of Ion Channel and Transporter Encoding Genes in Pediatric Gliomas
2012 Marika Masselli;Pasquale Laise;Giulia Tonini;Duccio Fanelli;Serena Pillozzi;Valentina Cetica;Martina Da Ros;Iacopo Sardi;Anna Maria Buccoliero;Maurizio Aricò;Lorenzo Genitori;Andrea Becchetti;Annarosa Arcangeli
Deterministic and stochastic aspects of VEGF-A production and the cooperative behavior of tumoral cell colony
2010 Pasquale Laise ; Francesca Di Patti ; Duccio Fanelli ; Marika Masselli ; Annarosa Arcangeli.
Deterministic and stochastic aspects of VEGF-A production and the cooperative behavior of tumoral cell colony.
2011 P.Laise; F.Di Patti; D.Fanelli; M.Masselli; A.Arcangeli
hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma
2015 Lastraioli, E; Perrone, G.; Sette, A.; Fiore, A.; Crociani, O.; Manoli, S.; D'Amico, M.; Masselli, M.; Iorio, J.; Callea, M.; Borzomati, D.; Nappo, G.; Bartolozzi, F.; Santini, D.; Bencini, L.; Farsi, M.; Boni, L.; Di Costanzo, F.; Schwab, A.; Onetti Muda, A.; Coppola, R.; Arcangeli, A.
hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer
2013 O Crociani; F Zanieri; S Pillozzi; E Lastraioli; M Stefanini; A Fiore; A Fortunato; M D'Amico; M Masselli; E De Lorenzo; L Gasparoli; M Chiu; O Bussolati; A Becchetti; A Arcangeli
Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells.
2008 L.Guasti;O.Crociani;E.Redaelli;S.Pillozzi;S.Polvani;M.Masselli;T.Mello;A.Galli;A.Amedei;RS.Wymore;E.Wanke;A.Arcangeli
Identification of Non-Cardiotoxic hERG1 Blockers to Overcome Chemoresistance in Acute Lymphoblastic Leukemias
2012 Marika Masselli; Serena Pillozzi; Massimo D'Amico
Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels
2016 Pillozzi, S.; Masselli, M.; Gasparoli, L.; D'Amico, M.; Polletta, L.; Veltroni, M.; Favre, C.; Basso, G.; Becchetti, A.; Arcangeli, A.
Method and kit for the prevention and/or the monitoring of the chemioresistance of leukaemia forms
2010 A. Arcangeli; A. Becchetti; S. Pillozzi; M. Masselli.; E. De Lorenzo.
Neoplasie della linea B emopoietica: inquadramento molecolare e identificazione di approcci terapeutici volti al superamento della chemioresistenza
2009 M.Masselli
New compositions of the treatment of chemoresistant and/or potentially chemoresistant leukemias
2010 Arcangeli A.; Becchetti A.; Pillozzi S.; Masselli M.; De Lorenzo E.
Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels.
2009 Serena Pillozzi; Marika Masselli; Emanuele De Lorenzo
Role of the Ether-a-go-go-Related Gene 1B Isoform in Hematopoiesis
2012 Serena Pillozzi; Marika Masselli; Marinella Veltroni
The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis.
2008 C. Becchi; S. Pillozzi; L. P. Fabbri; M. Al Malyan; C. Cacciapuoti; C. Della Bella; M. Nucera; M. Masselli; S. Boncinelli; A. Arcangeli; A. Amedei
The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma
2019 Magi A.; Masselli M.; Sala C.; Guerriero A.; Laise P.; Puccini B.; Rigacci L.; Breschi C.; Crociani O.; Pillozzi S.; Arcangeli A.; Serena Pillozzi
The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity
2015 L Gasparoli; M D'Amico; M Masselli; S Pillozzi; R Caves; R Khuwaileh; W Tiedke; K Mugridge; A Pratesi; J Mitcheson; G Basso; A Becchetti; A Arcangeli
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies. | 2012 | N. Shimasaki; H. Fujisaki; D. Cho; M. Masselli; T. Lockey ; P. Eldridge; W. Leung; D. Campana | |
| Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. | 2011 | S.Pillozzi; M.Masselli; E.De Lorenzo; B.Accordi; E.Cilia; O.Crociani; A.Amedei; M.Veltroni; M.D’Amico; G.Basso; A.Becchetti; D.Campana; A.Arcangeli | |
| Deregulation of Ion Channel and Transporter Encoding Genes in Pediatric Gliomas | 2012 | Marika Masselli;Pasquale Laise;Giulia Tonini;Duccio Fanelli;Serena Pillozzi;Valentina Cetica;Martina Da Ros;Iacopo Sardi;Anna Maria Buccoliero;Maurizio Aricò;Lorenzo Genitori;Andrea Becchetti;Annarosa Arcangeli | |
| Deterministic and stochastic aspects of VEGF-A production and the cooperative behavior of tumoral cell colony | 2010 | Pasquale Laise ; Francesca Di Patti ; Duccio Fanelli ; Marika Masselli ; Annarosa Arcangeli. | |
| Deterministic and stochastic aspects of VEGF-A production and the cooperative behavior of tumoral cell colony. | 2011 | P.Laise; F.Di Patti; D.Fanelli; M.Masselli; A.Arcangeli | |
| hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma | 2015 | Lastraioli, E; Perrone, G.; Sette, A.; Fiore, A.; Crociani, O.; Manoli, S.; D'Amico, M.; Masselli, M.; Iorio, J.; Callea, M.; Borzomati, D.; Nappo, G.; Bartolozzi, F.; Santini, D.; Bencini, L.; Farsi, M.; Boni, L.; Di Costanzo, F.; Schwab, A.; Onetti Muda, A.; Coppola, R.; Arcangeli, A. | |
| hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer | 2013 | O Crociani; F Zanieri; S Pillozzi; E Lastraioli; M Stefanini; A Fiore; A Fortunato; M D'Amico; M Masselli; E De Lorenzo; L Gasparoli; M Chiu; O Bussolati; A Becchetti; A Arcangeli | |
| Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells. | 2008 | L.Guasti;O.Crociani;E.Redaelli;S.Pillozzi;S.Polvani;M.Masselli;T.Mello;A.Galli;A.Amedei;RS.Wymore;E.Wanke;A.Arcangeli | |
| Identification of Non-Cardiotoxic hERG1 Blockers to Overcome Chemoresistance in Acute Lymphoblastic Leukemias | 2012 | Marika Masselli; Serena Pillozzi; Massimo D'Amico | |
| Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels | 2016 | Pillozzi, S.; Masselli, M.; Gasparoli, L.; D'Amico, M.; Polletta, L.; Veltroni, M.; Favre, C.; Basso, G.; Becchetti, A.; Arcangeli, A. | |
| Method and kit for the prevention and/or the monitoring of the chemioresistance of leukaemia forms | 2010 | A. Arcangeli; A. Becchetti; S. Pillozzi; M. Masselli.; E. De Lorenzo. | |
| Neoplasie della linea B emopoietica: inquadramento molecolare e identificazione di approcci terapeutici volti al superamento della chemioresistenza | 2009 | M.Masselli | |
| New compositions of the treatment of chemoresistant and/or potentially chemoresistant leukemias | 2010 | Arcangeli A.; Becchetti A.; Pillozzi S.; Masselli M.; De Lorenzo E. | |
| Overcoming Chemotherapy Resistance in Childhood Acute Lymphoblastic Leukemia by Targeting Ion Channels. | 2009 | Serena Pillozzi; Marika Masselli; Emanuele De Lorenzo | |
| Role of the Ether-a-go-go-Related Gene 1B Isoform in Hematopoiesis | 2012 | Serena Pillozzi; Marika Masselli; Marinella Veltroni | |
| The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. | 2008 | C. Becchi; S. Pillozzi; L. P. Fabbri; M. Al Malyan; C. Cacciapuoti; C. Della Bella; M. Nucera; M. Masselli; S. Boncinelli; A. Arcangeli; A. Amedei | |
| The ion channels and transporters gene expression profile indicates a shift in excitability and metabolisms during malignant progression of Follicular Lymphoma | 2019 | Magi A.; Masselli M.; Sala C.; Guerriero A.; Laise P.; Puccini B.; Rigacci L.; Breschi C.; Crociani O.; Pillozzi S.; Arcangeli A.; Serena Pillozzi | |
| The New Pyrimido-indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects Without Cardio-toxicity | 2015 | L Gasparoli; M D'Amico; M Masselli; S Pillozzi; R Caves; R Khuwaileh; W Tiedke; K Mugridge; A Pratesi; J Mitcheson; G Basso; A Becchetti; A Arcangeli |